Physician profile
Edwin B Moss
NPI 1801903638
$1,442.53
in general payments reported to CMS, 2019-2025
11 companies · $130 in 2025
The $130 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $171 · 2021: $149 · 2022: $65.17 · 2023: $434 · 2024: $255 · 2025: $130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $649 · Entertainment: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.58 |
| Entertainment | $169.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $344.77 | 2020-2024 | Clareon, Total30 |
| Optos, INC. | $169.87 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $145.44 | 2022-2024 | Myday Contact Lens |
| Sight Sciences, INC. | $129.54 | 2025 | Tearcare System |
| Kala Pharmaceuticals, INC. | $124.46 | 2021 | |
| Shire North American Group INC | $124.34 | 2019 | |
| Rxsight INC | $118.80 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Lkc Technologies, INC. | $118.52 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $114.84 | 2019 | |
| Abbvie INC. | $27.33 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.